A detailed history of High Tower Advisors, LLC transactions in Certara, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 19,612 shares of CERT stock, worth $187,294. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,612
Previous 28,316 30.74%
Holding current value
$187,294
Previous $392,000 41.58%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.46 - $16.58 $91,043 - $144,312
-8,704 Reduced 30.74%
19,612 $229,000
Q2 2024

Aug 13, 2024

SELL
$13.36 - $18.94 $39,892 - $56,554
-2,986 Reduced 9.54%
28,316 $392,000
Q1 2024

May 06, 2024

BUY
$15.65 - $19.45 $74,165 - $92,173
4,739 Added 17.84%
31,302 $559,000
Q4 2023

Feb 12, 2024

SELL
$12.12 - $18.19 $11,356 - $17,044
-937 Reduced 3.41%
26,563 $467,000
Q3 2023

Nov 08, 2023

BUY
$13.9 - $19.58 $75,991 - $107,043
5,467 Added 24.81%
27,500 $399,000
Q2 2023

Aug 14, 2023

BUY
$16.89 - $24.64 $59,047 - $86,141
3,496 Added 18.86%
22,033 $401,000
Q1 2023

May 11, 2023

BUY
$15.9 - $24.72 $11,273 - $17,526
709 Added 3.98%
18,537 $446,000
Q4 2022

Feb 08, 2023

BUY
$10.7 - $17.84 $17,665 - $29,453
1,651 Added 10.21%
17,828 $286,000
Q3 2022

Nov 09, 2022

SELL
$12.84 - $24.13 $41,062 - $77,167
-3,198 Reduced 16.51%
16,177 $215,000
Q2 2022

Aug 10, 2022

SELL
$16.75 - $22.54 $7,906 - $10,638
-472 Reduced 2.38%
19,375 $427,000
Q1 2022

May 12, 2022

BUY
$17.89 - $28.73 $148,164 - $237,941
8,282 Added 71.61%
19,847 $440,000
Q4 2021

Feb 10, 2022

SELL
$26.1 - $45.21 $201,987 - $349,880
-7,739 Reduced 40.09%
11,565 $332,000
Q3 2021

Nov 12, 2021

BUY
$24.46 - $38.41 $472,175 - $741,466
19,304 New
19,304 $644,000

Others Institutions Holding CERT

About Certara, Inc.


  • Ticker CERT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 159,899,008
  • Market Cap $1.53B
  • Description
  • Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...
More about CERT
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.